These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2318846

  • 1. Kinetic determination of the effects of ADP-ribosylation on the interaction of eukaryotic elongation factor 2 with ribosomes.
    Nygård O, Nilsson L.
    J Biol Chem; 1990 Apr 15; 265(11):6030-4. PubMed ID: 2318846
    [Abstract] [Full Text] [Related]

  • 2. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
    Nygård O, Nilsson L.
    Biochim Biophys Acta; 1985 Feb 20; 824(2):152-62. PubMed ID: 3970930
    [Abstract] [Full Text] [Related]

  • 3. Nucleotide binding to elongation factor 2 inactivated by diphtheria toxin.
    Burns G, Abraham AK, Vedeler A.
    FEBS Lett; 1986 Nov 24; 208(2):217-20. PubMed ID: 3780964
    [Abstract] [Full Text] [Related]

  • 4. Effect of elongation factor 2 and of adenosine diphosphate-ribosylated elongation factor 2 on translocation.
    Montanaro L, Sperti S, Testoni G, Mattioli A.
    Biochem J; 1976 Apr 15; 156(1):15-23. PubMed ID: 182140
    [Abstract] [Full Text] [Related]

  • 5. The mechanism of the protein-synthesis elongation cycle in eukaryotes. Effect of ricin on the ribosomal interaction with elongation factors.
    Nilsson L, Nygård O.
    Eur J Biochem; 1986 Nov 17; 161(1):111-7. PubMed ID: 3780730
    [Abstract] [Full Text] [Related]

  • 6. Effect of ADP-ribosylation and phosphorylation on the interaction of elongation factor 2 with guanylic nucleotides.
    Marzouki A, Sontag B, Lavergne JP, Vidonne C, Reboud JP, Reboud AM.
    Biochimie; 1991 Nov 17; 73(7-8):1151-6. PubMed ID: 1742357
    [Abstract] [Full Text] [Related]

  • 7. ADP-ribosylated elongation factor 2 (ADP-ribosyl-EF-2) is unable to promote translocation within the ribosome.
    Davydova EK, Ovchinnikov LP.
    FEBS Lett; 1990 Feb 26; 261(2):350-2. PubMed ID: 2311763
    [Abstract] [Full Text] [Related]

  • 8. Modification of the reactivity of three amino-acid residues in elongation factor 2 during its binding to ribosomes and translocation.
    Lavergne JP, Marzouki A, Reboud AM, Reboud JP.
    Biochim Biophys Acta; 1990 Apr 06; 1048(2-3):231-7. PubMed ID: 2322578
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells.
    Fendrick JL, Iglewski WJ, Moehring JM, Moehring TJ.
    Eur J Biochem; 1992 Apr 01; 205(1):25-31. PubMed ID: 1313365
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the ribosomal properties required for formation of a GTPase active complex with the eukaryotic elongation factor 2.
    Nygård O, Nilsson L.
    Eur J Biochem; 1989 Feb 15; 179(3):603-8. PubMed ID: 2537725
    [Abstract] [Full Text] [Related]

  • 11. 1-N6-Etheno-ADP-ribosylation of elongation factor-2 by diphtheria toxin.
    Giovane A, Balestrieri C, Quagliuolo L, Servillo L.
    FEBS Lett; 1985 Oct 28; 191(2):191-4. PubMed ID: 2996930
    [Abstract] [Full Text] [Related]

  • 12. Estimating the amounts of ADP-ribosylatable active elongation factor-2 in mammalian cell-free extracts.
    Riis B, Rattan SI, Clark BF.
    J Biochem Biophys Methods; 1989 Oct 28; 19(4):319-25. PubMed ID: 2693515
    [Abstract] [Full Text] [Related]

  • 13. On the nature of cellular ADP-ribosyltransferase from rat liver specific for elongation factor 2.
    Sayhan O, Ozdemirli M, Nurten R, Bermek E.
    Biochem Biophys Res Commun; 1986 Sep 30; 139(3):1210-4. PubMed ID: 3094526
    [Abstract] [Full Text] [Related]

  • 14. Eukaryotic elongation factor 2 loses its non-specific affinity for RNA and leaves polyribosomes as a result of ADP-ribosylation.
    Sitikov AS, Davydova EK, Bezlepkina TA, Ovchinnikov LP, Spirin AS.
    FEBS Lett; 1984 Oct 29; 176(2):406-10. PubMed ID: 6208057
    [Abstract] [Full Text] [Related]

  • 15. Interaction of phosphorylated elongation factor EF-2 with nucleotides and ribosomes.
    Dumont-Miscopein A, Lavergne JP, Guillot D, Sontag B, Reboud JP.
    FEBS Lett; 1994 Dec 19; 356(2-3):283-6. PubMed ID: 7805855
    [Abstract] [Full Text] [Related]

  • 16. On the mode of inhibition of eukaryotic protein synthesis by ADP-ribosylation of elongation factor 2.
    Nurten R, Albeniz I, Bermek E.
    IUBMB Life; 1999 Nov 19; 48(5):557-62. PubMed ID: 10637774
    [Abstract] [Full Text] [Related]

  • 17. Reduced turnover of the elongation factor EF-1 X ribosome complex after treatment with the protein synthesis inhibitor II from barley seeds.
    Nilsson L, Asano K, Svensson B, Poulsen FM, Nygård O.
    Biochim Biophys Acta; 1986 Oct 16; 868(1):62-70. PubMed ID: 3756169
    [Abstract] [Full Text] [Related]

  • 18. Receptor-mediated transport of the hybrid protein ricin-diphtheria toxin fragment A with subsequent ADP-ribosylation of intracellular elongation factor II.
    Youle RJ, Neville DM.
    J Biol Chem; 1979 Nov 10; 254(21):11089-96. PubMed ID: 500625
    [Abstract] [Full Text] [Related]

  • 19. Active-site mutations of the diphtheria toxin catalytic domain: role of histidine-21 in nicotinamide adenine dinucleotide binding and ADP-ribosylation of elongation factor 2.
    Blanke SR, Huang K, Wilson BA, Papini E, Covacci A, Collier RJ.
    Biochemistry; 1994 May 03; 33(17):5155-61. PubMed ID: 8172890
    [Abstract] [Full Text] [Related]

  • 20. Inhibition by ricin of protein synthesis in vitro. Inhibition of the binding of elongation factor 2 and of adenosine diphosphate-ribosylated elongation factor 2 to ribosomes.
    Montanaro L, Sperti S, Mattioli A, Testoni G, Stirpe F.
    Biochem J; 1975 Jan 03; 146(1):127-31. PubMed ID: 167711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.